Scott A. Noggle, PhD, is Director of Laboratory and Senior Research Fellow at the New York Stem Cell Foundation Laboratory and Adjunct Associate Research Scientist in Pediatrics and Molecular Genetics at Columbia University.  He was a postdoctoral fellow in the lab of Ali H. Brivanlou at The Rockefeller University where he previously managed the Stem Cell Derivation Core facility for the Tri-Institutional Stem Cell Initiative and studied the signaling pathways that maintain pluripotency and control neural induction.  He received his PhD from the Medical College of Georgia and his BS and MS from the University of Arkansas at Fayetteville.  His research interests include applying new advances in cell reprogramming to generate human models of neurodegenerative diseases, such as Alzheimer’s disease, which will open new avenues for drug discovery.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr. Stephen Chang joined NYSCF in 2010 after serving as Chief Scientific Officer of Stemgent upon the company's founding in 2008. He was previously the CEO of Multicell Technologies and continues as a director of this company. Prior to that, he was the CEO of Astral Immunotherapy which was acquired by Multicell Technologies in 2005. Previously, he was chief science officer (CSO) and vice president of Canji Inc. / Schering Plough Research Institute in San Diego from 1998 to 2004. He has also held senior management positions at Chiron and Viagene. Dr. Chang is president of CURES, a coalition of patient advocates, biotechnology companies, pharmaceutical companies, and venture capitalists dedicated to ensuring the safety, research, and development of innovative life saving medications. He is also a board member of Histogen a privately held company in regenerative medicine. Dr. Chang earned his doctoral degree in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine.

Dr. Chang's research interest is in the area of translational applications of basic science to pharmaceutical products. He holds over 20 patents and has initiated or been responsible for over nineteen IND involving novel biologic and small molecule compounds. A biochemical geneticist by training, Dr. Chang has been involved in HIV therapeutics, cancer therapeutics, vaccine applications, arthritis, multiple sclerosis, ophthalmology, hepatitis and stem cell research.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Faizzan comes to NYSCF with two years of experience working with Embryonic Stem Cells jointly in the labs of Dr. Stewart Anderson from Weill Cornell Medical College and Dr. Lorenz Studer from Memorial Sloane-Kettering Cancer Center where he studied the directed differentiation of embryonic stem cells towards specific interneuron fates. He received a BA in Biology from the City University of New York at Queens College.  At Vanderbilt University he worked with Dr. Randy Blakely studying acetylcholine reuptake via the choline transporter protein and then later went on to Dr. R. Daniel Beauchamp’s lab studying the requirement of smad4 in TGFbeta induced epithelial to mesenchymal transdifferentiation (EMT).  He's also worked with Dr. John Boockvar at Weill Cornell studying neural stem cell motility and Dr. David Sassoon at the Mount Sinai School of Medicine studying muscle development. His current interests lie in developing efficient techniques for iPS cell generation as well as directing the differentiation stem cells in order to develop cell-based therapies and cellular models to study brain disorders.   
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Lauren comes to NYSCF with administrative experience and two years in the Lykke-Andersen Lab in the Department of MCD Biology at the University of Colorado, Boulder, studying the mechanism of mRNA decay. She is currently pursuing a MS in Biotechnology at Johns Hopkins University and received a BA cum laude in Molecular, Cellular, and Developmental Biology from the University of Colorado, Boulder. She also participated in a study abroad program in Perugia, Italy.  
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Jennifer joins NYSCF with experience in protocol development and clinical research support. She came to us from Memorial Sloan-Kettering Cancer Center where she was a Senior Protocol Development Coordinator in the Office of Clinical Research. Previously, she was a research assistant in the Department of Breast Surgery (also at MSKCC). She has a BS in Biology from Fordham University.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Carmen Dusenberry currently focuses on generating induced pluripotent stem (iPS) cells from Alzheimer's patients in order to further study the disease and identify opportunities for new treatments. Previously, she worked in health care, publishing, and hospitality. She earned a BS degree in Biological Sciences at Fordham University, where she presented research on ZFN mediated gene disruption and the effects of polyphenols on the cardiovascular system..

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr. Egli also has been appointed as a Research Scientist in Pedriatics & Molecular Genetics at Columbia University, in the group of Dr. Rudolf Leibel. He received his PhD from the University of Zurich, Switzerland, and until recently, he was a postdoctoral fellow in the laboratory of Kevin Eggan at the Department of Stem Cell and Regenerative Biology, Harvard University, studying reprogramming after nuclear transfer. His interest includes the generation of therapeutically relevant cells.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Valentina Fossati joined the NYSCF team as Helmsley investigator in January 2011. Her current interests include autoimmune diseases and particularly multiple sclerosis. She received her PhD at the University of Bologna. She joined Dr. Hans Snoeck’s lab in 2006, while still a PhD student. She has been working on the development of the immune system, focusing on B lymphocytes first and, as a post doctoral fellow, on the generation of thymic epithelial cells from embryonic stem cells. She was the recipient of a NYSCF – Druckenmiller Fellowship in 2009.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Haiqing Hua, PhD, joined NYSCF in 2009. He has also been appointed as a Post-Doctoral fellow in Pedriatics & Molecular Genetics at Columbia University, in the group of Dr. Rudolf Leibel. He received his PhD from the University of Zurich, Switzerland. His interests include the generation of patient-specific stem cells and ß-cell differentiation.

 

Samson Jacob joined the NYSCF staff in the summer of 2010. He comes to us from Weill Cornell Medical College where he worked under Dr. John P. Moore studying HIV-1 viral entry and the development of inhibitory drugs for HIV-1.  Samson graduated from SUNY-Binghamton with a B.S. in Cell Molecular Biology. His current research focus involves using iPS cells to model Alzheimer’s Disease. 
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David J. Kahler, PhD, manages the NYSCF laboratory and provides technical and scientific support to facility users. He operates the cell sorter and works closely with NYSCF laboratory users in designing and optimizing protocols for sorting fragile stem cell populations. He received his PhD in Molecular Medicine and Immunology from the Medical College of Georgia in the lab of Andrew Mellor where he studied the phenotype, function, and lineage of a rare subset of immunomodulatory dendritic cells found in humans and mice. He obtained dual BS degrees in Paper Science and Engineering and Chemical Engineering from the University of Washington in Seattle. He worked as a process engineer for Kimberly-Clark and Weyerhaeuser and as a scanning and transmission electron microscopist in an environmental and materials testing laboratory.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Darja Marolt, PhD received her Phd from the university of Ljubljana, Slovenia. She has been developing tissue engineering approaches to regenerate bone, working at the Blood Transfusion Center of Slovenia and the MIT-harvard division of health Sciences and Technology. She has co-authored ten research papers, and is currently completing her post-doctoral studies in the department of Biomedical engineering at Columbia university. She was the recipient of a NYSCF – druckenmiller Fellowship in 2007.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Hector Martinez joined the NYSCF team in November 2009. He came to us from The Rockefeller University, where he worked with Noble Laureate Dr. Paul Greengard studying the components of the signal transduction cascade responsible for the regulation of Amyloid precursor protein breakdown and the formation of Aβ, with the aim of developing new targets for the treatment of Alzheimer’s disease. His current interests lie in the generation of patient-specific stem cells that allow modeling of human genetic diseases in vitro with the hope to provide cell based therapies that are suited to clinical application.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dorota Moroziewicz  MSc,  joined NYSCF from Columbia University with extensive experience in molecular biology and immunology.  She earned a Masters Degree in Medical Technology from the Medical University of Białystok, Poland and a Masters Degree in Molecular Biology from Long Island University in NYC. Dorota works in the Flow Cytometry and High Throughput Screening laboratories and is focused on developing  innovative stem cell technologies. This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Daniel Paull joined NYSCF in January 2010, working as a postdoctoral research fellow under Dr Dieter Egli and Professor Rudolph Leibel. He has submitted a PhD at University College London, England, which explored the effects of differing anti-scarring agents, and delivery methods, in their ability to regulate the wound healing response that follows glaucoma surgery. His PhD followed a BSc in Neuroscience from the University of Sheffield, England, where he first gained interest in the role of stem cells. His work at NYSCF will encompass the use of iPS cells in diabetes research, as well as continuing to explore the roles of nuclear transfer and cell reprogramming.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Anita received her Masters degree in biochemical studies at the Max Planck Institute of Molecular Genetics in Berlin, with a main focus on RNAi.     After this she begain working in the field of tissue engineering and studied the behaviour of primary human chondrocytes and osteoblasts under different cell culture conditions. This included the use of different cell culture techniques, as monolayer cultures or 3D cultures on different scaffold materials as well as the stimulation by growth factors.  Anita is currently a research technician at NYSCF with main focus on the generation of iPS cells.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Linshan Shang, PhD, joined NYSCF in spring 2010.  She came to us from the Department of Surgery, Columbia University, with two years of postdoctoral experience working on cardiovascular diseases. She received her PhD from Shandong University, China, where she worked on neural stem cells and aging. Her current research focuses on the use of stem cells to study diabetes.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Andrew Sproul, PhD, joined NYSCF in early 2010. His current research focuses on the use of iPS and ES cells to study Alzheimer’s Disease. He received his PhD from Columbia University, where he studied neuronal cell death in the laboratory of Dr. Lloyd Greene.  Before starting at NYSCF, he did a short postdoc researching neurogenesis in the laboratory of Dr. Sergei Sokol at the Mount Sinai School of Medicine. Prior to graduate school, he worked for four years in bacterial research, including three in the laboratory of Sir Hans Kornberg at Boston University, where he studied the evolution of novel fructose metabolic pathways. In his spare time he enjoys practicing kung fu and cooking.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Liheng Wang, Joined NYSCF in 2010. She is a predoctoral graduate student in the laboratory of  Dr. Rudolf Leibel at the Institute of Human Nutrition, Columbia University. Her current interest focuses on the study of obesity and its related diseases (such as BBS) by using iPS and human ES cells.

Keren Weiss joined NYSCF in early 2011 after spending several years working as an Andrology Scientist in the field of Assisted Reproductive Technology (ART) in Sydney, Australia. Her primary focus in her previous clinical role included diagnostic testing and cryopreservation. She was also heavily involved in research and process improvement, specifically looking at improving sperm DNA testing, cryopreservation media and automation. She has received both a Bachelor of Science and Master of Science in Medicine (Reproductive Health and Human Genetics) from The University of Sydney, Australia.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it